|
Subsequent Event
|
9 Months Ended |
|---|---|
|
Sep. 30, 2014
|
|
| Subsequent Event [Abstract] | |
| Subsequent Event |
(8) Subsequent Events
On October 24, 2014, we effected a one for fifty reverse stock split approved by our Board of Directors and majority shareholders.
On October 24, 2014, we changed our name to PlasmaTech Biopharmaceuticals, Inc.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. No definition available.
|